Antimalarial agents in pregnancy [2]

Lancet

Volumn 359, Issue 9305, 2002, Pages 524-525

  Motta, Mario ^a   Tincani, Angela ^a   Faden, David ^a   Zinzini, Enrica ^a   Chirico, Gaetano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; HYDROXYCHLOROQUINE;

ANTIPHOSPHOLIPID SYNDROME; BIRTH WEIGHT; BREAST FEEDING; CONGENITAL MALFORMATION; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DRUG HALF LIFE; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFECTION PREVENTION; LETTER; MALARIA; NEWBORN MONITORING; NONHUMAN; OPHTHALMOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETINOPATHY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; CHEMICALLY INDUCED DISORDER; EYE DISEASE; FEMALE; FETOMATERNAL TRANSFUSION; NEWBORN; NOTE;

ANTIMALARIALS; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 0037045506     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07643-2     Document Type: Letter

References (5)

1. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
2. Safety of chloroquine in chemosuppression of malaria during pregnancy
3. Antimalarial drugs in pregnancy: The North American experience
4. The motor quotient: A method for the early determination of motor delay
5. The use of hydroxychloroquine in lupus pregnancy: The British experience